Background Parenchymal Signal Enhancement Ratio at Preoperative MR Imaging: Association with Subsequent Local Recurrence in Patients with Ductal Carcinoma in Situ after Breast Conservation Surgery

医学 危险系数 乳腺癌 磁共振成像 乳房磁振造影 机构审查委员会 放射科 组内相关 保乳手术 比例危险模型 导管癌 活检 乳房外科 手术切缘 乳房成像 乳房切除术 乳腺摄影术 内科学 癌症 外科 置信区间 临床心理学 心理测量学
作者
Sun Ah Kim,Nariya Cho,Eun Bi Ryu,Mirinae Seo,Min Sun Bae,Jung Min Chang,Woo Kyung Moon
出处
期刊:Radiology [Radiological Society of North America]
卷期号:270 (3): 699-707 被引量:54
标识
DOI:10.1148/radiol.13130459
摘要

To retrospectively investigate whether the background parenchymal features around a tumor at preoperative dynamic contrast material-enhanced magnetic resonance (MR) imaging are associated with ipsilateral breast tumor recurrence (IBTR)-free survival in patients with ductal carcinoma in situ (DCIS) after breast conservation surgery.The institutional review board approved this study, and the requirement for informed consent was waived. Between 2004 and 2009, 215 consecutive women with pure DCIS who had undergone preoperative dynamic contrast-enhanced MR imaging and curative breast conservation surgery were identified. Clinical-pathologic features (age, menopausal status, presentation of clinical findings, biopsy method, tumor size, nuclear grade, hormonal receptor status, margin status, and adjuvant therapy) and MR imaging features (lesion size, background parenchymal enhancement grade, fibroglandular density, parenchymal signal enhancement ratio [SER] around the tumor, lesion type, and lesion kinetics) were analyzed. A Cox proportional hazards model was used to determine the association between MR imaging variables and IBTR-free survival after controlling for clinical-pathologic variables. Reproducibility of SER measurements was evaluated by using the intraclass correlation coefficient.There were 15 of 215 (7.0%) IBTR cases (nine DCIS cases and six invasive cases) at a median of 36 months (range, 11-61 months). Multivariate analysis showed that higher parenchymal SER (hazard ratio [HR] = 2.028, P < .001 for reader 1; HR = 1.652, P < .001 for reader 2) and larger histologic tumor size (HR = 1.360, P = .009 for reader 1; HR = 1.402, P = .006 for reader 2) were independent factors associated with worse IBTR-free survival. The intraclass correlation coefficient of SER measurements between two readers was 0.852 (95% confidence interval: 0.811, 0.885).Higher parenchymal SER around the tumor at preoperative dynamic contrast-enhanced MR imaging and larger histologic tumor size were independent factors associated with worse IBTR-free survival in patients with DCIS after breast conservation surgery.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
高磊发布了新的文献求助10
1秒前
RH完成签到,获得积分10
1秒前
zhangzhen完成签到,获得积分10
1秒前
2秒前
科研通AI2S应助zfzf0422采纳,获得10
4秒前
Wendy1204发布了新的文献求助10
5秒前
5秒前
lydy1993完成签到,获得积分10
6秒前
7秒前
滴滴哒哒完成签到 ,获得积分10
7秒前
SciGPT应助波波玛奇朵采纳,获得10
9秒前
戏言121完成签到,获得积分10
9秒前
迷人的映雁完成签到,获得积分10
10秒前
10秒前
美丽的之双完成签到,获得积分10
11秒前
阿会完成签到,获得积分10
11秒前
wqm完成签到,获得积分10
12秒前
戏言121发布了新的文献求助10
13秒前
13秒前
14秒前
优雅的流沙完成签到 ,获得积分10
15秒前
猫的海完成签到,获得积分10
15秒前
15秒前
Eason Liu完成签到,获得积分0
16秒前
Wendy1204完成签到,获得积分20
16秒前
Hello应助654采纳,获得10
16秒前
咩咩羊完成签到,获得积分10
16秒前
20秒前
lianqing完成签到,获得积分10
20秒前
汉堡包应助科研通管家采纳,获得10
20秒前
领导范儿应助科研通管家采纳,获得10
21秒前
RC_Wang应助科研通管家采纳,获得10
21秒前
科研通AI5应助科研通管家采纳,获得10
21秒前
所所应助科研通管家采纳,获得10
21秒前
FashionBoy应助科研通管家采纳,获得10
21秒前
赘婿应助科研通管家采纳,获得10
21秒前
hh应助科研通管家采纳,获得10
21秒前
所所应助科研通管家采纳,获得10
21秒前
丘比特应助科研通管家采纳,获得10
21秒前
搜集达人应助科研通管家采纳,获得30
21秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
Luis Lacasa - Sobre esto y aquello 700
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527990
求助须知:如何正确求助?哪些是违规求助? 3108173
关于积分的说明 9287913
捐赠科研通 2805882
什么是DOI,文献DOI怎么找? 1540119
邀请新用户注册赠送积分活动 716941
科研通“疑难数据库(出版商)”最低求助积分说明 709824